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Abstract
Background: Schistosomiasis is still a major public health burden in the tropics and subtropics. Although there is an
effective chemotherapy (Praziquantel) for this disease, reinfection occurs rapidly after mass drug administration (MDA).
Because the entire population do not get reinfected at the same rate, it is possible that host factors may play a dominant
role in determining resistance or susceptibility to reinfection with schistosomes. Here, we systematically reviewed and meta-
analyzed studies that reported associations between reinfection with the principal human-infecting species (S. mansoni, S.
japonicum and S. haematobium) and host socio-demographic, epidemiological, immunological and genetic factors.
Methodology/Principal Findings: PubMed, Scopus, Google Scholar, Cochrane Review Library and African Journals Online
public databases were searched in October 2013 to retrieve studies assessing association of host factors with reinfection
with schistosomes. Meta-analysis was performed to generate pooled odds ratios and standardized mean differences as
overall effect estimates for dichotomous and continuous variables, respectively. Quality assessment of included studies,
heterogeneity between studies and publication bias were also assessed. Out of the initial 2739 records, 109 studies were
included in the analyses, of which only 32 studies with 37 data sets were eligible for quantitative data synthesis. Among
several host factors identified, strong positive association was found with age and pre-treatment intensity, and only slightly
for gender. These factors are major determinants of exposure and disease transmission. Significant positive association was
found with anti-SWA IgG4 level, and a negative overall effect for association with IgE levels. This reconfirmed the concept
that IgE/IgG4 balance is a major determinant of protective immunity against schistosomiasis. Other identified determinants
were reported by a small number of studies to enable interpretation.
Conclusions: Our data contribute to the understanding of host-parasite interaction as it affects reinfection, and is a
potential tool to guide planning and tailoring of community interventions to target high-risk groups.
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Introduction
Schistosomiasis is still an important helminthic infection in terms
of severe morbidity that can result as a consequence of infection.
Over 200 million people are infected and more than 700 million
people are still at risk of getting infected with schistosomiasis [1].
Although the disease can be effectively treated with Praziquantel,
reinfection occurs rapidly after mass drug administration (MDA).
An effective vaccine used singly or in combination with chemo-
therapy is the optimum approach [2]. However, such a vaccine is
presently not available, although some candidates are still in the
development pipeline. Since chemotherapy by MDA is presently
the only available intervention in endemic areas, there is need to
identify the host factors that increase susceptibility to reinfection
with schistosomes for targeted intervention in high-risk groups.
In addition to the demographic, socioeconomic and epidemi-
ological variables that may predispose certain subset of the
population to reinfection, several human studies in endemic areas
have provided insight into the potential resistance inducing
immune response phenotypes [2–8]. Many of these studies have
found associations between reinfection with schistosomes and IgE/
IgG4 balance. Schistosomiasis has previously been shown to be
under the control of the cytokine genes cluster on chromosome
5q31-q33 region, called SM1 [7,9,10]. It is also possible that
several other immunogenetic factors in addition to this cytokine
genes cluster, including the genes controlling IgE levels, may be
associated with reinfection with schistosomiasis [11–15]. However,
it remains to be determined whether variations in these genes or
which of the variations in these genes are potential determinants of
reinfection.
We undertook this meta-analysis to identify and describe studies
that had identified host determinants, including socio-demograph-
ic, epidemiological and immunogenetic factors that are associated
with reinfection with schistosomes.
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Methods
Protocol registration
This study was performed in accordance with the recommen-
dations of the PRISMA statement [16,17]. This statement
summarized in the PRISMA 2009 checklist is supplied as
supplementary information (Figure S1). The protocol for this
study was determined prior to commencement of the study, and
was registered in PROSPERO-International prospective register
of systematic reviews with identification number
CRD42013006582 available from http://www.crd.york.ac.uk/
PROSPERO/display_record.asp?ID = CRD42013006582.
Eligibility criteria
Studies that assessed host factors of reinfection with schisto-
somes were included in this review. While all eligible studies on all
identified host determinants were included in the qualitative
systematic review, only factors reported by more than one study
and whose data can be reliably extracted were included in the
quantitative meta-analysis. All relevant studies were included
irrespective of study type, study design, language and date. We
limited included studies to studies performed on human subjects.
Reports were excluded if the reported information was on a study
performed on animals, if they were case studies, correspondence or
reviews, and if the data could not be reliably retrieved. Decisions
on eligibility were made by two independent reviewers and all
discrepancies and disagreements as regards study and report
eligibility were resolved by discussion or consensus with a third
reviewer, when necessary.
Information source
Studies analyzed in this review were identified by searching
electronic public databases including: PubMed (http://www.ncbi.
nlm.nih.gov/pubmed), Scopus (http://www.scopus.com/), Goo-
gle Scholar (http://scholar.google.com/), Cochrane Review
Library (http://www.cochrane.org/cochrane-reviews) and Afri-
can Journals Online (AJOL) (http://www.ajol.info/index.php/
index/search). The searches were performed in October 2013
with no limit set for the dates of publications. Reference lists of
eligible articles were also checked to obtain supplementary
information and records of potentially relevant studies and reports.
Efforts were made to contact authors for full texts, clarification on
data and for supplementary data, when necessary. When responses
with the necessary details were not received from authors during
the duration of the study and after two reminders, such studies
were excluded and classified as ‘‘full text not available’’.
Search strategy
Initial searches were performed on PubMed and Scopus
databases using the broad search term: ‘‘((reinfection OR re-
infection OR resistance OR resistant OR susceptibility OR
susceptible OR haplotype OR allele OR SNP OR ‘‘single
nucleotide polymorphism’’ OR variant OR polymorphism OR
‘‘genetic factors’’ OR HLA OR ‘‘human leucocyte antigen’’) AND
(schistosom* OR bilharzi*))’’ to retrieve socio-demographic,
epidemiological and immunogenetic factors. For Advanced
Google Scholar, we filled in the term ‘‘schistosoma OR
schistosomiasis OR schistosome OR bilharzia OR bilharziasis’’
in the field ‘‘with all of the word’’, and the words ‘‘reinfection OR
re-infection OR resistance OR resistant OR susceptibility OR
susceptible OR ‘‘host factors’’ OR ‘‘genetic factors’’ OR haplotype
OR allele OR SNP OR ‘‘single nucleotide polymorphism’’ OR
variant OR polymorphism, in the field ‘‘with at least one of the
words’’ to search the titles of articles in Google scholar database.
The Cochrane Library and African Journals Online databases
were searched with the broad term ‘‘schistosoma OR schistoso-
miasis OR bilharzia OR bilharziasis’’.
Study selection
Two independent reviewers performed initial eligibility assess-
ments on the retrieved titles and abstracts, for inclusion in the
systematic review. Full texts of eligible articles were then retrieved
and reviewed for inclusion in the systematic review, and further
screened for inclusion in the meta-analysis using the inclusion
criteria. In both steps of the screening, inclusion or exclusion of a
study by both reviewers was considered conclusive, while inclusion
or otherwise of studies judged eligible, controversial or ambiguous
by either of the reviewers was resolved by discussion and consensus
between the two reviewers. When necessary, disagreements and
discrepancies were resolved by consensus with a third reviewer.
Care was taken to identify more than one report describing a
single study. When such was encountered, the overlap was
identified and resolved, with contacts made to the authors when
necessary. The study selection procedure was summarized in a
systematic review flow chart.
Data collection process and data items
We adopted the methodology and data extraction template of
The Review Manager (RevMan v5.2) from The Nordic Cochrane
Centre, Cochrane Collaboration, 2012 for data extraction, in
addition to other relevant data items as determined by the
reviewers. As much as possible, the following pieces of information
were obtained from eligible study reports by two independent
reviewers, in a non-blinded manner: study ID (lead author name
and year), study type, study period, study location, problem
addressed (reinfection with schistosomes), species studied, host
factors assessed, study aim, recruitment, inclusion, exclusion,
informed consent, ethical approval, number of participants, study
completion rate, statistical methods and funding. Given that the
host factors we identified and reviewed were not set a priori, the
factors were included on first observation. Thus, a study assessing
several host factors was included respectively in the meta-analysis
for each of the factors; while overlap from multiple reports
referring to a single study was resolved to avoid duplication. When
studies in different locations were separately reported in a single
Author Summary
One of the major challenges of schistosomiasis control is
that disease prevalence reverts to baseline levels after
mass drug administration due to high rate of reinfection.
Host factors play a major role in determining resistance or
susceptibility to reinfection with schistosomiasis and other
diseases. We systematically searched and analyzed studies
that identified potential host determinants of reinfection
with schistosomes. Among demographic variables, age but
not gender was strongly associated with reinfection with
schistosomes. Pretreatment infection intensity was also
identified as a major determinant of reinfection. Positive
association with IgG4 levels and negative association with
IgE levels reconfirmed the notion that IgE/IgG4 balance is
the major factor controlling protective immunity against
schistosomiasis. Other factors were reported by few
studies to allow correct inferences. These results contrib-
ute to our understanding of host-parasite relationship as it
affects reinfection, and will be useful for planning and
targeting the limited resources for intervention on high-
risk groups.
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article, the study was included twice for each of the areas
differentiated using footnotes.
Quality assessment of included studies
To assess risk of bias within selected studies, we adopted the
quality assessment tool in the Cochrane RevMan v5.2 program.
Briefly, this method takes into account four factors: selection bias
by evaluating the sampling and randomization procedure,
performance bias by assessing the level of blinding of personnel,
detection bias by evaluating the level of blinding of outcome
assessment, and reporting bias by assessing the presence of
selective reporting in data presentation. We created a quality
scoring system based on these RevMan v5.2 quality assessment
items, with levels of risk of bias scored as ‘‘21’’ for high risk, ‘‘0’’
for unclear risk and ‘‘1’’ for low risk of bias. These parameters
(n = 4), in addition to availability of descriptions of (n = 8): host
determinants, outcomes definitions, inclusion criteria, exclusion
criteria, method of diagnosis, mass chemotherapy, confirmation of
cure prior to inclusion and follow-up period, were used to create a
quality score based on 12 items on a scale of 100% for each
included study (Table S1).
Assessment of risk of bias across studies
To assess the risk of bias across studies, Begg’s funnel plots were
generated to assess publication bias across the reviewed studies
[18,19]. Funnel plots were created for each factor by plotting the
effects measure (odds ratio) against the standard error of its
logarithm. The symmetries of the funnel plots were first assessed
visually. When potential publication bias was identified, the trim
and fill method proposed by Duvall and Tweedie [20] was applied.
No further test of bias or symmetry of the funnel was performed
since no publication bias was apparent.
Definition of outcomes and risk factors
The outcomes definitions were pre-determined by the review-
ers, and all included studies sufficiently satisfy these criteria.
Briefly, ‘‘resistance to reinfection’’ was defined as absence of
parasite egg in multiple parasitological examinations after
treatment (and confirmation of cure), followed by a follow-up
period (for uniformity, data on ,12 months follow-up were
pooled) despite exposure to the parasite. Conversely, ‘‘susceptibil-
ity to reinfection’’ was defined as positive parasitological exami-
nation within 6 to 12 months after chemotherapy and cure.
Among the risk factors identified, we adopted ,10 years old as the
definition for younger children. This was because all the included
studies defined younger children as either ,9 or ,10 years old,
apart from three studies that defined younger children as ,13, ,
14 and ,15 years old, respectively (Table S1). High (moderate to
high) pretreatment infection intensities was defined as .50 eggs/
10 ml of urine for S. haematobium, and .100 eggs/g of feces for
S. mansoni and S. japonicum. For antibody levels, only data from
studies utilizing the predetermined established method (ELISA)
were pooled. While slight variations exist in the methods adopted
in each study for estimation of antibody levels, these were ignored
since similar conditions apply for the comparator in each study.
Only data from studies satisfying these definitions were pooled in
data synthesis.
Quantitative data synthesis (meta-analyses)
Data from eligible studies were combined using meta-analysis
performed on The Review Manager (RevMan v5.2) from The
Nordic Cochrane Centre, Cochrane Collaboration, 2012 [21]. We
meta-analyzed and interpreted all host factors reported in more
than one studies without setting any cut off for the minimum
number of studies required for valid interpretation. For each
identified host factor reported as dichotomous outcome, 262
contingency tables were generated and the odds ratio (OR) with
the corresponding 95% confidence intervals (95% CI) were
calculated. For studies reporting continuous outcomes (such as
antibody levels), the input data was mean and standard deviation
(SD) with the standardized mean difference (SMD) as the effect
measure. When the standard deviation was not reported, it was
computed with the calculator function in RevMan v5.2, using
other supplied data (e.g. mean, SEM, p-value etc.). For each factor
analyzed, a forest plot showing the respective odds ratios or
standardized mean differences with their corresponding 95%
confidence interval for each study and for the pooled data were
generated. The test of overall effect was assessed using the Z-
statistics on RevMan v5.2 with statistical significance set at p,
0.05. Subgroup analysis based on species studied was performed
when necessary, especially for host factors with sufficient number
of included studies.
Test of heterogeneity between studies
Heterogeneity (inconsistency) between studies was evaluated
using the Cochrane Q (Chi2 test) and I2 statistics in RevMan v5.2
[22]. The statistical significance for heterogeneity using the Chi2
test was set as p,0.10. Estimates of degree of heterogeneity using
I2 were made by setting 25%, 50%, or 75% as limits for low,
moderate or high heterogeneity, respectively [22]. The fixed-
effects model with weighting of the studies was used when there
was a lack of significant heterogeneity (p.0.10), while the random-
effects model with weighting of the studies was used when there
was heterogeneity between studies (p,0.10) and I2 values of over
50%. A major drawback of the random-effects model is that it
assigns relatively equal weight to studies. Therefore, fixed-effects
model was preferred over random-effects, although random-effects
model was still applied when significant heterogeneity was
recorded between studies.
Sensitivity analysis
For sensitivity analysis, we adopted the methods recommended
for Cochrane systematic reviews. Each meta-analysis of the
association of reinfection with a host factor was reanalyzed with
the exclusion of each individual study to examine the effect of a
single study on the outcome of meta-analysis. In addition, to
examine the effect of the largest and smaller studies on the
outcome of the meta-analysis, cumulative meta-analysis was
performed with studies ordered according to the sample size.
Also, sensitivity testing to identify the effect of subgroups was
performed by subgroup analysis. This was achieved by comparing
the results of the meta-analysis after exclusion of each subgroup.
Results
Study selection
Using the broad search terms, initial screening of public
databases yielded 2739 study reports. Out of these studies, 295
were included for full text reading based on initial title and abstract
screening using the inclusion criteria. The two reviewers agreed
with 284 decisions and 11 discrepancies were resolved by
discussion and consensus. For some reasons that are outlined in
Figure 1, further 186 study reports were excluded and a total of
109 studies identifying 39 host factors were included for the data
synthesis. However, some of the identified host determinants were
reported by only 1 study and were further excluded in the final
meta-analysis. Finally, 32 study reports on 26 host determinants of
Host Determinants of Reinfection with Human Schistosomes
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reinfection were included in the final quantitative data synthesis
(meta-analysis). Five of these study reports were on two
independent data sets [23–27], thus, a total of 37 datasets were
included in the meta-analysis (Figure 1).
Characteristics of included studies
The characteristics of the 32 studies included in the meta-
analysis were fully described in Table S1. This table outlined the
study ID, study location, study period, sample size, gender ratio,
age range and species studied. Out of the 32 included studies; 13
were on reinfection with Schistosoma mansoni, 7 were on S.
japonicum, 10 studies assessed reinfection with S. haematobium,
and 2 studies were on both S. mansoni and S. haematobium. Based
on the population of subjects studied; 20 studies were on both
children and adults, 11 studies were on children alone, while only
1 study was on adult subjects alone. All included studies were
cohort studies (n = 32), with prospective data collection method
(Table S1).
Quality assessment of included studies
Assessment of risk of bias within selected studies was performed
using the quality assessment tool in Cochrane RevMan v5.2
program, modified as detailed in the Method section. The result of
the quality assessment based on the 12 items on a scale of 100%
showed that only 2 studies scored the maximum points (100%).
The other included studies scored over 75% points in the study
quality assessment, indicating their suitability for inclusion in the
meta-analysis (Table S1).
Synthesis of results and meta-analysis
A total of 39 host factors comprising socio-demographic,
epidemiological, immunological, genetic variants and other
variables were identified from the included studies. However, 13
of these host determinants were reported in only one study and
were subsequently excluded in the meta-analysis. The full list of 39
identified host factors with their corresponding statistics and effect
Figure 1. Flow diagram for the search and systematic review process.
doi:10.1371/journal.pntd.0003164.g001
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Table 1. Host determinants of reinfection with schistosomes identified in this study.
Host Factors No Reps Model Heterogeneity Association Study References
X2 (p-val.) I2 OR/SMD (95% CI) Z (p-val.)
1. Demographic factors
Age (,10) 19 Rand. p,0.0001 74 1.91 [1.41, 2.60] p,0.0001 [24,26,28–42]
Gender (M) 20 Rand. p,0.0001 88 1.45 [1.02, 2.05] p = 0.04 [24–26,28–32,34–36,39,40,42–46]
2. Epidemiological factors
PTI 7 Rand. p = 0.006 67 2.85 [1.97, 4.12] p,0.0001 [26,27,30,36,40]
Exposure 4 Rand. p,0.0001 91 2.34 [0.93, 5.85] p = 0.07 [36,40,42,44]
HTA 5 Rand. p,0.0001 91 2.24 [0.63, 7.91] p = 0.21 [37,42,44,47]
3. Antibodies
? IgE
SWA 7 Rand. p,0.0001 88 20.06 [20.59, 0.46] p = 0.82 [23,31,39,44,49,53]
SEA 8 Rand. p = 0.001 71 20.03 [20.38, 0.32] p = 0.88 [23,31,39,44,48–51]
? IgG4
SWA 5 Fixed p = 0.38 5 0.47 [0.26, 0.68] p,0.0001 [23,31,39,44,49]
SEA 9 Rand. p,0.0001 89 0.41 [20.13, 0.95] p = 0.14 [23,31,39,44,48–51]
? IgG1
SWA 4 Rand. p,0.0001 89 0.71 [0.06, 1.37] p = 0.03 [23,31,45,49]
SEA 5 Rand. p = 0.005 73 0.56 [0.10, 1.03] p = 0.02 [23,31,48,49,51]
? IgG2
SWA 3 Rand. p,0.0001 90 0.67 [20.15, 1.49] p = 0.11 [23,31,49]
SEA 4 Rand. p,0.0001 92 0.87 [0.02, 1.71] p = 0.04 [23,31,49,51]
? IgG3
SWA 2 Rand. p = 0.04 77 20.22 [20.85, 0.42] p = 0.51 [31,49]
SEA 3 Fixed p = 0.70 0 0.04 [20.21, 0.29] p = 0.77 [31,49,51]
? IgA
SWA 3 Rand. p,0.0001 95 0.50 [20.67, 1.67] p = 0.40 [23,31,49]
SEA 5 Rand. p,0.0001 93 0.54 [20.42, 1.50] p = 0.27 [23,31,48,49,51]
? IgM
SWA 3 Rand. p,0.0001 98 1.84 [21.11, 4.79] p = 0.22 [23,31,49]
SEA 3 Rand. p,0.0001 96 1.19 [20.50, 2.89] p = 0.17 [23,31,51]
4. Cytokines
IFN-g 4 Fixed p = 0.36 1 20.22 [20.52, 0.08] p = 0.15 [6,44,45,48]
IL-10 4 Fixed p = 0.08 56 20.15 [20.44, 0.13] p = 0.29 [6,44,45,48]
TNF-a 2 Rand. p = 0.03 79 20.27 [20.77, 0.22] p = 0.28 [6,51]























































































estimates were included as supplementary information (Table S2).
The summary of the meta-analyses on 26 host factors, including:
the number of pooled studies, data analyses model adopted, the
tests of heterogeneity, association analyses and the study
references were presented in Table 1. Several demographic,
epidemiological and immunological variables were identified,
with some of the variables showing strong association with
reinfection with schistosomes. These are further described in
subsequent sections.
Association of demographic factors with reinfection with
schistosomes
1. Age (,10 years old). Age was identified as a major factor
that may predispose certain subsets of the population to reinfection
with schistosomes. In this review, we assessed the odds of
reinfection among children less than 10 years old as compared
to the rest of the population (Figure 2). Significant heterogeneity
was observed among the included studies (p,0.0001, I2 = 74%),
therefore, random effects model was applied for the meta-analysis.
This heterogeneity was probably due to the variability of the
studied populations. While some of the studies were on school-
aged children (5–18 years range), others included the whole
population (Table S1). Pooled odds ratio showed that younger age
(,10 years old) was positively associated with reinfection with
schistosomes (OR = 1.91, 95% CI = 1.41–2.60, Z = 4.15,
p,0.0001) (Figure 2).
Sensitivity analysis by analysis of subgroups based on the species
studied showed that while reinfection with S. mansoni [28–32] and
S. haematobium [26,33–40] showed strong association with age,
such association was not observed when only studies on S.
japonicum [24,41,42] were considered (Figure 2). The positive
association between reinfection and age (,10 years old) lost its
statistical significance (p = 0.13) when all the studies on S.
haematobium subgroup were excluded from the meta-analysis
(Table S3). Also, sensitivity analysis by exclusion of a single study
from the analysis (Table S3) or cumulative meta-analysis (Table
S4) showed that the result of the meta-analysis was robust as the
inclusion or exclusion of any single study did not affect the
outcome of the odds ratio, Z-score and p-value.
2. Gender (male). We also assessed whether gender (being
male) was a predisposing factor of reinfection with schistosomes.
Because there was significant heterogeneity among the studies (p,
0.0001, I2 = 88%), random effects model was applied. Pooled odds
ratio showed that although there was a positive association of male
gender and reinfection with schistosomes, the association was only
slightly statistically significant (OR = 1.45, 95% CI = 1.02–2.05,
Z = 2.09, p = 0.04). Sensitivity analysis by subgroup analysis based
on the species studied showed that statistically significant positive
association was observed for association of male gender with
reinfection with S. mansoni (p = 0.02) [25,28–32,43–45] and S.
japonicum (p = 0.002) [24,42,46], while the association for
reinfection with S. haematobium [26,34–36,39,40] was not
statistically significant (p = 0.30) (Figure 3). The exclusion of S.
mansoni or S. japonicum subgroups in the meta-analysis yielded
effect measures which were not statistically significant (p = 0.22
and p = 0.23, respectively). Conversely, the exclusion of data from
S. haematobium subgroup significantly affected the result of the
meta-analysis (OR = 1.85, 95% CI = 1.34–2.55, Z = 3.76,
p = 0.0002) (Table S3). Furthermore, sensitivity analyses by
exclusion of single studies (Table S3) and cumulative meta-analysis
(Table S4) showed that two large studies [26,34] significantly
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Association of epidemiological factors with reinfection
with schistosomes
Three major epidemiological factors of reinfection were
identified, including: pre-treatment infection intensity
[26,27,30,36,40], rate of exposure [36,40,42,44] and levels of
transmission in the studied area [37,42,44,47]. There was strong
positive association between high (moderate to high) pretreatment
infection intensities (.50 eggs/10 ml of urine for S. haematobium,
and .100 eggs/g of feces for S. mansoni and S. japonicum) and
reinfection with schistosomes (OR = 2.85, 95% CI = 1.97–4.12,
Z = 5.57, p,0.0001). (Figure 4A). The positive association be-
tween high rates of exposure (we defined high rate of exposure as
‘‘above average’’ exposure rate for a specific population as
determined by authors) and reinfection with schistosomes was
not statistically significant (OR = 2.34, 95% CI: 0.93–5.85,
Z = 1.81, p = 0.07) (Figure 4B). Although there was also a positive
correlation between residence in high transmission area and
reinfection, the association was not statistically significant
(OR = 2.24, 95% CI = 0.63–7.91, Z = 1.25, p = 0.21) (Figure 4C).
Association of immunological factors with reinfection
with schistosomes
Among the immunological factors identified in this review, most
studies reported association between humoral responses and
probability of reinfection with schistosomes. An interesting finding
was a negative standardized mean difference observed in the
Figure 2. Association of younger age (,10 years old) with reinfection with schistosomes. Presented here is the meta-analysis forest plot
showing the pooled odds ratio and the corresponding 95% CI, subgroup analysis by species, and assessment of heterogeneity among studies. There
was a strong statistically significant positive association between younger age (,10 years old) and reinfection with schistosomes.
doi:10.1371/journal.pntd.0003164.g002
Host Determinants of Reinfection with Human Schistosomes
PLOS Neglected Tropical Diseases | www.plosntds.org 7 September 2014 | Volume 8 | Issue 9 | e3164
association between IgE levels and reinfection with schistosomes
(Figure 5 and Figure S2) inferred from meta-analysis on 8 studies
[23,31,39,44,48–51]. However, subgroup analyses of these asso-
ciations with IgE levels against adult worm antigen (SWA)
(Figure 5A) and egg antigen (SEA) (Figure 5B) were not statisti-
cally significant (For anti-SWA IgE, SMD = 20.06, 95% CI = 2
0.59–0.46, Z = 0.23, p = 0.82; for anti-SEA IgE, SMD = 20.03,
95% CI = 20.38–0.32, Z = 0.15, p = 0.88). Sensitivity analysis by
exclusion of individual studies showed that the exclusion of any of
the included studies in this meta-analysis did not affect the pooled
effect estimates (Table S3).
Conversely, strong positive association was observed between
IgG4 levels and reinfection with schistosomes (Figure 6 and Figure
S2). However, while the association between reinfection and anti-
SWA IgG4 levels was statistically significant (SMD = 0.47, 95%
CI = 0.26–0.68, Z = 4.35, p,0.0001) (Figure 6A); the association
between reinfection and anti-SEA IgG4 levels was not statistically
significant (SMD = 0.41, 95% CI = 20.13–0.95, Z = 1.48,
p = 0.14) (Figure 6B). Sensitivity analysis showed that while the
exclusion of any single study did not affect the result of the
association between reinfection with schistosomes and anti-SWA
IgG4 levels, the exclusion of one study [39] resulted in positive
association with statistical significance for the association of anti-
SEA IgG4 with reinfection with schistosomes (Table S3).
Equally, positive associations were observed for association of
reinfection with schistosomes with levels of IgG1, IgG2, IgA and
Figure 3. Association of gender (male) with reinfection with schistosomes. Presented here is the meta-analysis forest plot showing the
pooled odds ratio and the corresponding 95% CI, subgroup analysis by species, and assessment of heterogeneity among studies. The observed
positive association between reinfection and gender was only slightly significant.
doi:10.1371/journal.pntd.0003164.g003
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IgM against SWA (Figure S3A, B, D and E) and SEA (Figure S4A,
B, D and E); while negative association was observed between
reinfection and levels of IgG3 (Figure S3C and Figure S4C).
However, there were limited number of studies reporting these
factors and the associations were not statistically significant except
for IgG1.
Some cellular immune response factors were also identified.
However, there were consistently small number of studies
reporting these factors, and the associations were not statistically
significant (Table 1 and Table S2). We observed negative
standardized mean differences from the associations of reinfection
with levels of IFN-c, IL-5, IL-10, IL-13, TNF-a and CD4+ T-
helper cells; and positive effect estimates from the association of
reinfection with proportions of CD8, CD19 and CD16 positive
cells. Other factors including the HLA gene polymorphisms, levels
of total protein, albumin, total cholesterol, low-density lipoproteins
and very low-density lipoproteins were also identified. However,
these factors were all reported by only one study (Table S2).
Risk of bias across studies
To assess outcome reporting bias and publication bias across
studies, we generated funnel plots for two representative host
Figure 4. Association of epidemiological factors with reinfection with schistosomes. (A) Meta-analysis forest plot for the association of
reinfection with high pretreatment intensity showing positive association with reinfection. (B) Forest plot for the association of reinfection with high
rate of exposure showing association with reinfection without statistical significance. (C) Meta-analysis forest plot for the association of reinfection
with residence in high transmission area did not show statistically significant association with reinfection.
doi:10.1371/journal.pntd.0003164.g004
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factors with sufficient number of included studies (age and gender)
by plotting the odds ratio (OR) on the x-axis, and the standard
error of the log of odds ratio (SE(log[OR]) on the y-axis (Figure 7).
The funnel plot showed the typical cone appearance with good
symmetry, with the studies apparently distributed on either side of
the pooled outcome effect estimate (Figure 7). Two outlier studies
[29,32] observed from the association of reinfection with age were
of significantly small size (Figure 7A). To exclude potential small
study effect, these studies were excluded and their exclusion did
not affect the result of the pooled effect size. Equally, we also
applied the trim and fill method proposed by Duvall and Tweedie
[20] by adding studies equivalent to these outliers, which appear to
be missing. Again, this did not affect the symmetry and the result
of the pooled effect estimate. Also, subgroup analysis showed that
all studies on S. japonicum were on the left side of the cone unlike
the other species. However, exclusion of this subgroup (Table S3),
or trim and fill method did not affect the results of the combined
effect estimates. These indicate that there is minimal publication
bias in these studies and no further test of bias was carried out.
Discussion
Identification of host factors that predispose certain subsets of
the population to reinfection with schistosomes, and indeed any
other disease, is a major strategy that will guide planning and
tailoring of community interventions to target high-risk groups. It
is also important for targeting health education and limited
resources for disease prevention. Our meta-analysis has identified
some of the host determinants of reinfection with schistosomes.
The outcomes showed strong positive association with age, and
pretreatment intensity of infection, and only slight association with
gender. Also, the IgE/IgG4 balance, which is well recognized as a
major determinant of reinfection [2–5], was again reconfirmed by
our meta-analysis. Our results showed that younger age and
pretreatment intensity of infection, which are connected with
behavioral differences in population subsets and disease transmis-
sion, play predominant role in determining the probability of
reinfection with schistosomes. This is due to differences in rate of
exposure, but not necessarily absence of protective immunity [52].
Conversely, the immunological parameters related with protective
immunity, which may itself be associated with age and accumu-
lated experience [40,52–56]; also play major role in determining
protection from infection but not exposure to the pathogen. It can
therefore be inferred that exposure and age-related factors play a
predominant role in disease transmission, while immunological
factors control protective immunity against reinfection.
Younger age was positively associated with the rate of
reinfection. Schistosomes are transmitted through skin penetration
by the infective cercariae during water contact activities. Given
that younger children are mainly involved in such high-risk water
Figure 5. Association of IgE levels with reinfection with schistosomes. (A) Meta-analysis forest plot for the association of reinfection with
anti-SWA IgE levels showing the pooled standardized mean difference and the corresponding 95% CI and assessment of heterogeneity among
studies. The observed negative overall effect was not statistically significant. (B) Meta-analysis forest plot for the association of reinfection with anti-
SEA IgE levels showing the pooled standardized mean difference and the corresponding 95% CI and assessment of heterogeneity among studies. The
observed negative overall effect was not statistically significant.
doi:10.1371/journal.pntd.0003164.g005
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contact activities like domestic chores and recreation, this result is
expected and is consistent with the results of other big intervention
studies [26,30,34,36]. However, species based subgroup analysis
did not show positive association between age and reinfection with
S. japonicum. It is not clear whether this is related to differences in
the study cultural settings since unlike S. haematobium and S.
mansoni; the distribution of S. japonicum is limited to South East
Asia. However, limited number of studies assessed reinfection with
S. japonicum, and unlike studies on the other species which
sometimes involved only children, all studies on S. japonicum
involved both adults and children; a major source of heterogeneity
among the included studies. Also, S. japonicum has some
peculiarities that may also contribute to the observed heterogene-
ity, including: its zoonotic nature, the generally much lower
prevalence (especially in recent decades) and the fact that exposure
is often mainly during occupational activities instead of domestic
and recreational ones.
Our analyses showed only slight association between gender and
reinfection with schistosomes. Although boys and girls may have
major behavioral but not biological differences that can affect rate
of reinfection [28], this distinction is very minimal among the
younger age group. Even among the older children, there are only
changes in the kind of water contact activities, which may not
necessarily translate to major change in rate of exposure to the
disease. Surprisingly, subgroup analysis showed strong positive
association between gender and reinfection with S. japonicum.
Although this may be due to differences in gender role in various
cultural settings, the observed association may not be very reliable
since the analysis was based on only four studies on S. japonicum.
Also on cultural differences, Fulford et al. (1996) and other workers
identified that patterns of water contact vary dramatically between
even culturally rather similar communities [57,58]. Therefore,
absence of strong association with gender even with apparent
behavioral differences between genders remains inconclusive. This
implies that gender difference in reinfection pattern varies in
difference cultural settings [58].
Apart from the demographic factors, three major epidemiolog-
ical factors were positively correlated with reinfection: high pre-
treatment intensity, high rate of exposure and residence in high
transmission area. High pretreatment intensity is related to
possibility of failed or incomplete treatment [36], especially when
studies did not include a follow up study dedicated to confirming
cure in the treated population. As would be expected, there was
also a positive correlation between reinfection and high exposure
rate as inferred from the four studies assessing this factor, but
the association was not statistically significant. Although some
studies distinguished between high transmission areas and low
transmission areas based on relative availability of potable
water and sanitation [36], there was no association between
residence in either of these areas, and rate of reinfection with
schistosomes. This could be because water contact activities do
not depend exclusively on lack of domestic water or sanitation,
Figure 6. Association of IgG4 levels with reinfection with schistosomes. (A) Meta-analysis forest plot for the association of reinfection with
anti-SWA IgG4 levels showing the pooled standardized mean difference and the corresponding 95% CI and assessment of heterogeneity among
studies. IgG4 level was highly significantly associated with reinfection with schistosomes. (B) Meta-analysis forest plot for the association of
reinfection with anti-SEA IgG4 levels showing the pooled standardized mean difference and the corresponding 95% CI and assessment of
heterogeneity among studies. The observed positive overall effect was not statistically significant.
doi:10.1371/journal.pntd.0003164.g006
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Figure 7. Funnel plots for assessment of publication bias. (A) Funnel plots for assessment of publication bias for studies assessing association
of reinfection with age showing lack of significant publication bias in the included studies. (B) Funnel plots for assessment of publication bias for
gender.
doi:10.1371/journal.pntd.0003164.g007
Host Determinants of Reinfection with Human Schistosomes
PLOS Neglected Tropical Diseases | www.plosntds.org 12 September 2014 | Volume 8 | Issue 9 | e3164
but is a function of several interrelated factors, including:
perception, distinct cultural practices and the need for
recreation. These render residence in either high or low
transmission areas less important as a risk factor of reinfection
with schistosomes.
Among the immunological factors identified, most studies
reported association between different antibody isotype levels
and probability of reinfection with schistosomes. Interestingly, a
negative association was recorded from the association between
IgE levels and reinfection with schistosomes. On the other hand,
strong positive association was observed between IgG4 levels and
reinfection with schistosomes. These observations are consistent
with the consensus perspective that IgE/IgG4 balance plays
central role in controlling protective immunity against infection or
reinfection with schistosomes [2–5,8,31,38,39,41,44,56,59–63].
While increased IgE levels are protective against infection and
reinfection, elevated IgG4 levels increase predisposition to
infection and reinfection. Recent studies have found strong
association between IgE levels and certain loci in the human
genome, including: the cytokine gene cluster on chromosome
5q31-q33 (SM1), which also controls infection with schistosomiasis
[7,64–67]; FCER1A on chromosome 1q23, which is the gene
encoding the alpha chain of the high affinity receptor for IgE
[11,14]; STAT4 on chromosome 2q32 [12,64] which controls Th1
development; STAT6 on chromosome 12q13 [12,13,15,64] and
GATA3 on chromosome 10p15 [12,64] which control Th2
development; and the Th2 cytokine receptor cluster in 16p12
region of the human genome [7,64]. We had expected to identify
studies assessing association between reinfection and several
immunogenetic factors including variations in these loci; however,
there were few or no studies on the host immunogenetic factors of
reinfection with schistosomes, an important theme for further
research. We are presently proposing a study that will identify
association between major single nucleotide polymorphisms
(SNPs) in these loci, and reinfection with schistosomes and other
helminthic infections.
Our analyses on cellular immune response factors showed
negative effect estimates for the associations of reinfection with
levels of IFN-c, IL-5, IL-10, TNF-a and CD4+ T-helper cells; and
positive effect estimates for the association of reinfection with the
proportions of CD8+, CD19+ and CD16+ cells. However, these
inferences are not very reliable since there was consistently limited
number of studies reporting these host factors, and the associations
were not statistically significant (Table 1 and Table S2). An
interesting observation though is the negative effect estimate
recorded from the association of reinfection with schistosomes with
levels of IFN-c. Studies in both human and animal models have
shown that protective immunity against schistosomiasis is mainly
Th1 dependent [2,4,6,68–75]. The egg antigen drives a dominant
Th2 response. Thus, induction and sustenance of a Th1
environment at the acute phase of infection thru onset of egg
deposition is required for sterile and anti-pathology protection
[68,69,75–78]. Negative effect estimates were also recorded from
the association of reinfection with levels of IL-5 and IL-13. This is
consistent with the notion that these cytokines control release and
survival of eosinophil [31], which has been shown to induce antibody
dependent protective immunity against schistosomiasis [79,80].
Other factors including the HLA gene polymorphisms, levels of total
protein, albumin, total cholesterol, low-density lipoproteins and very
low-density lipoproteins were also identified. However, these factors
were all reported by only one study (Table S2).
In conclusions, this study has identified the major host determi-
nants of resistance or susceptibility to reinfection with schistosomes;
although we had anticipated studies on immunogenetic factors in
addition to the identified socio-demographic, epidemiological
and immunological factors. Therefore, there is need to explore
the association between reinfection with schistosomes and host
immunogenetic factors, especially the variations in the genes
controlling immune response against schistosomiasis. This will
be an interesting subject for further studies. Strong association
with age and water contact related factors has reaffirmed that
these factors play dominant role in determining exposure to
pathogen and disease transmission. We also reconfirmed the
major role played by IgE/IgG4 balance in controlling protective
immunity against infection and reinfection with schistosomes.
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